{
"id":"mk19_a_id_q072",
"number":72,
"bookId":"id",
"correctAnswer":"A",
"title":"Question 72",
"stimulus":[
{
"type":"p",
"hlId":"5a5615",
"children":[
"A 29-year-old woman is evaluated for cough and fever of 2 days' duration. She has a history of cystic acne, which is treated with a topical retinoid cream and daily minocycline."
]
},
{
"type":"p",
"hlId":"d0d52a",
"children":[
"On physical examination, temperature is 38.3 °C (100.9 °F), blood pressure is 110/70 mm Hg, pulse rate is 90/min, and respiration rate is 20/min. ",
{
"type":"reference-range-link",
"referenceRange":"Blood gases, Oxygen saturation, arterial (ambient air)",
"children":[
"Oxygen saturation"
]
},
" is 93% breathing ambient air. Decreased breath sounds are heard at the right lung base."
]
},
{
"type":"p",
"hlId":"decb61",
"children":[
"COVID-19 testing is negative."
]
},
{
"type":"p",
"hlId":"a3f06a",
"children":[
"A chest radiograph shows a right lower lobe infiltrate."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"1054f1",
"children":[
"Which of the following is the most appropriate treatment?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Amoxicillin"
}
},
{
"letter":"B",
"text":{
"__html":"Ceftriaxone and azithromycin"
}
},
{
"letter":"C",
"text":{
"__html":"Cefuroxime and doxycycline"
}
},
{
"letter":"D",
"text":{
"__html":"Doxycycline"
}
},
{
"letter":"E",
"text":{
"__html":"Levofloxacin"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"f513fd",
"hvc":true,
"children":[
"In otherwise healthy persons with community-acquired pneumonia, amoxicillin or doxycycline are appropriate treatment options."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"447357",
"children":[
"Amoxicillin is the most appropriate therapy for this patient (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
"). Her score on the Pneumonia Severity Index screening scale is zero; therefore, outpatient therapy for community-acquired pneumonia (CAP) is appropriate. In healthy persons, treatment options are amoxicillin or doxycycline (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
"). Amoxicillin is preferred in this patient because of her chronic therapy with another tetracycline, minocycline, which is a recognized risk factor for development of doxycycline resistance. An alternative treatment option would be monotherapy with a macrolide if local pneumococcal resistance is less than 25%."
]
},
{
"type":"p",
"hlId":"5c324f",
"children":[
"Ceftriaxone and azithromycin or levofloxacin monotherapy are recommended regimens for hospitalized patients with nonsevere pneumonia (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B, E"
]
},
"). Because this patient has no risk factors for adverse outcomes, she does not require hospitalization and can be safely treated with an oral regimen as an outpatient."
]
},
{
"type":"p",
"hlId":"b0ec36",
"children":[
"Cefuroxime and doxycycline or levofloxacin monotherapy are appropriate choices for outpatient therapy in patients with medical comorbidities but are overly broad for a healthy patient with minimal risk factors for resistant organisms (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
"). Specific conditions for which combination oral therapy or a respiratory fluoroquinolone are indicated include underlying cardiac, respiratory, liver, or kidney disease; diabetes mellitus; malignancy; alcohol use disorder; or asplenia. Specific respiratory fluoroquinolones recommended in the 2019 American Thoracic Society/Infectious Diseases Society of America CAP management guideline include levofloxacin, moxifloxacin, and gemifloxacin; ciprofloxacin is not active against ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Streptococcus pneumoniae"
]
},
", precluding use of this agent for CAP monotherapy."
]
}
],
"relatedSection":"mk19_a_id_s3_4_2",
"objective":{
"__html":"Treat community-acquired pneumonia in an otherwise healthy outpatient."
},
"references":[
[
"Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45-e67. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31573350",
"target":"_blank"
},
"children":[
"PMID: 31573350"
]
},
" doi:10.1164/rccm.201908-1581ST"
]
],
"hospitalist":false,
"hvc":true,
"peerComparison":{
"A":14,
"B":47,
"C":6,
"D":5,
"E":27
},
"hlIds":[
"5a5615",
"d0d52a",
"decb61",
"a3f06a",
"1054f1",
"f513fd",
"447357",
"5c324f",
"b0ec36"
]
}